Protagen, Mikrogen Collaborate Friday, November 13, 2015 Protagen and Mikrogen have agreed on a co-development program for a new diagnostic assay to distinguish between previously infected, seropositive individuals, from newly infected patients with active Lyme disease. Coronavirus Breakthrough Thursday, November 12, 2015 Protein mutation affects spread and virulence of respiratory virus.New, Better Test for Prostate Cancer Wednesday, November 11, 2015 A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA. Circadian Clock Controls Insulin and Blood Sugar in Pancreas Tuesday, November 10, 2015 Map of thousands of genes suggests new therapeutic targets for diabetes.Cellular Stress Process Identified in Cardiovascular Disease Tuesday, November 10, 2015 Combining the investigative tools of genetics, transcriptomics, epigenetics and metabolomics, a Duke Medicine research team has identified a new molecular pathway involved in heart attacks and death from heart disease.Blood Test Picks Out Prostate Cancer Drug Resistance Tuesday, November 10, 2015 Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.Antibody Targets Key Cancer Marker Tuesday, November 10, 2015 University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine. Congenica, GenomOncology Announce Collaborative Agreement at AMP Thursday, November 05, 2015 Congenica and GenomOncology announce a pilot collaboration that will support the commercialisation of each other’s products in the USA and UK respectively and offer strategic partners a scalable data platform.
Affymetrix and Athletigen Partner Thursday, October 29, 2015 Partnership agreement to advance genetics in human athletic performance.